Literature DB >> 6265426

N-Formimidoyl thienamycin (MK0787): in-vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam and other beta-lactam antibiotics.

D Hanslo, A King, K Shannon, C Warren, I Phillips.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6265426     DOI: 10.1093/jac/7.6.607

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  15 in total

1.  Prospective randomized controlled study of ciprofloxacin versus imipenem-cilastatin in severe clinical infections.

Authors:  H Lode; R Wiley; G Höffken; J Wagner; K Borner
Journal:  Antimicrob Agents Chemother       Date:  1987-10       Impact factor: 5.191

2.  In vitro activity of N-formimidoyl-thienamycin in comparison to that of moxalactam and cefotaxime against gentamicin-resistant gram-negative bacteria.

Authors:  Z Pusztai-Markos; F Pranada
Journal:  Eur J Clin Microbiol       Date:  1982-02       Impact factor: 3.267

3.  Synergism between N-formimidoyl thienamycin and gentamicin or tobramycin against enterococci.

Authors:  C Watanakunakorn; J C Tisone
Journal:  Antimicrob Agents Chemother       Date:  1982-12       Impact factor: 5.191

4.  The in vitro activity of N-formimidoyl thienamycin compared with other broad-spectrum cephalosporins and with clindamycin and metronidazole.

Authors:  G Tischhauser; F H Kayser
Journal:  Infection       Date:  1983 Jul-Aug       Impact factor: 3.553

5.  Lack of in vivo and in vitro bactericidal activity of N-formimidoyl thienamycin against enterococci.

Authors:  R Auckenthaler; W R Wilson; A J Wright; J A Washington; D T Durack; J E Geraci
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

Review 6.  Imipenem/cilastatin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  S P Clissold; P A Todd; D M Campoli-Richards
Journal:  Drugs       Date:  1987-03       Impact factor: 9.546

7.  Comparative activities of 13 beta-lactam antibiotics.

Authors:  H L Muytjens; J van der Ros-van de Repe
Journal:  Antimicrob Agents Chemother       Date:  1982-06       Impact factor: 5.191

8.  A comparison of the antibacterial activities of N-formimidoyl thienamycin (MK0787) with those of other recently developed beta-lactam derivatives.

Authors:  W Cullmann; W Opferkuch; M Stieglitz; U Werkmeister
Journal:  Antimicrob Agents Chemother       Date:  1982-08       Impact factor: 5.191

9.  Susceptibility of Neisseria meningitidis and Neisseria gonorrhoeae isolates to N-formimidoyl thienamycin.

Authors:  E J Dudek; J D Stephenson; M Bohnhoff; S A Lerner
Journal:  Antimicrob Agents Chemother       Date:  1982-11       Impact factor: 5.191

10.  [N-formimidoyl-thienamycin: in vitro activity in bacteria with resistance to beta-lactam antibiotics or gentamicin].

Authors:  K Bartmann; R Tarbuc
Journal:  Infection       Date:  1982 Nov-Dec       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.